Welcome to our first installment of our “Drill Down & Catch Up” series, part of the broader “A New Era of Neuroscience” initiative.
In our initial post, we expressed cautious optimism about transformational changes in various areas of neuroscience over the next 1-5 years. Here, we highlight a few key August 2024 data readouts and regulatory decisions in psychiatric disorders and list select upcoming events in the back half of 2024, including:
• A wave of new antidepressants
• Psychedelics
• Novel mechanisms of action for schizophrenia
Disclaimer: “Drill Down & Catch Up” segments are not comprehensive but designed to deliver topical information and stimulate thought and discussion. We welcome your comments and opportunities to learn more about your neuroscience programs.
Lumanity offers extensive experience-based strategic guidance and insights in the field of neuroscience. Our goal is to provide our clients with actionable solutions that de-risk and optimize the development and commercialization of therapies, ultimately improving the lives of patients who are impacted across a range of conditions.
